The 'Hypertension Optimal Treatment' (HOT) study: Results of 12-month treatment related to age;Die 'Hypertension Optimal Treatment' (HOT)-studie: Behandlungsergebnisse nach zwolfmonatiger therapie in abhangigkeit vom alter

Deutsche Medizinische Wochenschrift

Volumn 123, Issue 1-2, 1998, Pages 1-5

  Kolloch, R E ^a   Rahn, K H ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FELODIPINE; ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; PLACEBO; THIAZIDE DIURETIC AGENT;

AGE; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; AGED; COMPARATIVE STUDY; DIASTOLE; FEMALE; FOLLOW UP; MALE; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RISK FACTOR; TIME;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ASPIRIN; CALCIUM CHANNEL BLOCKERS; DIASTOLE; DIURETICS; FELODIPINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED; PLACEBOS; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; RISK FACTORS; SODIUM CHLORIDE SYMPORTER INHIBITORS; TIME FACTORS;

EID: 0032472354     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1023890     Document Type: Article

References (6)

1. Collins, R., R. Peto, S. MacMahon: Blood pressure, stroke, and coronary heart disease. Part 2, short term reductions in blood pressure. Overview of randomized drug trials in their epidemiological context. Lancet 335 (1990), 827-838.
2. Hansson, L., T. Hedner, B. Dahlöf: Prospective Randomized open Blinded End-point (PROBE) Study. A Novel design for intervention trials. Blood Pressure 1 (1992), 113-119.
3. Hansson, L., A. Zanchetti for the HOT-Study-Group: The Hypertension Optimal Treatment (HOT) Study. Patient characteristics. Randomisation, risk profiles, and early blood pressure results. Blood Pressure 3 (1994), 322-327.
4. Hansson, L., A. Zanchetti for the HOT-Study-Group: The Hypertension Optimal Treatment (HOT) Study: 12-month data on blood pressure and tolerability. With special reference to age and gender. Blood Pressure 4 (1995), 313-319.
5. The HOT Study Group. The Hypertension Optimal Treatment (HOT) Study. Blood Pressure 2 (1993), 62-68.
6. Zanchetti, A., J. Chalmers, K. Arakawa et al.: The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Pressure 2 (1993), 86-100.